At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
HoloLens v2device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization
In Brief
A clinical study evaluating HoloLens v2 for Breast Cancer. Completed, enrolled 27 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the accuracy, set-up time, and amount of image-guided radiotherapy (IGRT - a system that helps line up the radiation beam with the tumor for treatment) needed when mixed-reality guided radiotherapy is used for treatment set-up.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsFlorida Breast Cancer Foundation
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJan 2022
Enrollment StartAug 2022
Primary CompletionSep 2023
TodayJul 2026
First PostedJan 5, 2022
Enrollment StartAug 2, 2022
Primary CompletionSep 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 4.5 years ago
Interventions
HoloLens v2device
The HoloLens v2 will be used to access the participant's hologram \& set the participant up for treatment. Standard of care methods will be utilized to confirm treatment set-up.